YANCOPOULOS GEORGE sold REGN
May 15, 2024 · Form 4 insider transaction
YANCOPOULOS GEORGE sold 9,851 shares of Regeneron Pharmaceuticals, Inc. at $977.42 per share, a transaction worth $9.63M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Disposition/acquisition made pursuant to plans intended to comply with Rule 10b5-1(c) adopted on February 14, 2024.; Represents volume-weighted average price of sales of 9,851 shares of Company stock on May 15, 2024 at prices ranging from $977.00 to $977.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 15, 2024 at each separate price.